Biểu đồ giá cổ phiếu ONCO
ONCO Dự đoán giá cổ phiếu
Onconetix Inc
$0.38
-5.94%
$-0.02
Khi đóng cửa: May 08, 16:00:00 GMT-4
$0.37
-1.31%
$0
Phiên trước giờ: May 11, 04:38:40 GMT-4
Quay lại
Onconetix Inc (ONCO) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$0.404
Giá mở cửa
$0.3955
Phạm vi ngày
$0.36 - $0.4
Phạm vi 52 tuần
$0.375 - $74.3
Khối lượng
852.2K
Khối lượng trung bình
5.1M
Tỷ suất cổ tức
--
EPS (TTM)
-74.35
Vốn hóa thị trường
$258.7K
ONCO là gì?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
